The MT-CO2 gene is part of mitochondrial DNA and helps your cells use oxygen to make energy. If it does not work properly, energy production can fall, especially in the brain, muscles, heart, and other tissues that need a steady supply. People with disease-causing variants in the MT-CO2 gene may develop a mitochondrial condition with features such as muscle weakness, poor exercise tolerance, seizures, developmental delay, or vision and hearing problems. Because this gene sits in mitochondrial DNA, these variants are usually passed down through the mother.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Other genes are used mainly to regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
MT-CO2Gene function
What if the gene works
The MT-CO2 gene provides instructions for part of a protein complex in your cells’ energy centers that helps use oxygen to make energy. This supports steady function in the brain, muscles, and heart.
Risk
What if the gene does not work
Variants in the MT-CO2 gene can impair energy production and lead to mitochondrial disease, often affecting muscles, the nervous system, or vision. Effects range from mild exercise intolerance to earlier, more severe weakness, seizures, stroke-like episodes, or vision loss.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the MT-CO2 gene, no MT-CO2-specific treatment or drug choice approach is currently established in clinical guidelines.
Conditions associated with MT-CO2
Gene function
What if the gene works
Every moment, your cells need a steady supply of energy to keep muscles moving, nerves signaling, and organs working. The MT-CO2 gene helps with one of the last steps in this process inside mitochondria, the parts of cells that make most of their usable energy. This helps cells turn oxygen and food into ATP.
The MT-CO2 gene helps a mitochondrial enzyme accept electrons from cytochrome c, a small helper protein that carries energy-rich particles. It passes those electrons deeper into the enzyme so energy production can keep moving.
This protein supports the final oxygen-using step in the cell’s energy pathway. In that step, oxygen is turned into water as part of normal energy production in mitochondria.
By helping this enzyme work properly, the MT-CO2 gene helps build a stored charge across the mitochondrial membrane. Your cells use that stored energy to make ATP, the main fuel they use every day.
What is a variant?
Genetic variants are common, small differences in the DNA sequence within a gene. They are part of normal human diversity and help explain differences in features, metabolism, and the way the body reacts to environmental influences. Many do not have any noticeable effect and are simply a natural part of genetic variation. In some situations, though, a variant changes how a gene works more strongly and can contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
MT-CO2 gene variants affect energy production by changing a key piece of complex IV, an energy making unit in mitochondria. Some variants slightly alter the protein’s shape, stability, or ability to move electrons, while more severe variants can sharply reduce complex IV assembly or activity, so cells make less energy. This functional range can help explain why disease linked to the MT-CO2 gene may begin earlier or affect more body systems in some people.
How variants are linked to conditions
Pathogenic variants in the MT-CO2 gene can cause mitochondrial disease, most often mitochondrial complex IV deficiency, and may confirm the diagnosis in the right clinical setting. In reports on MT-CO2 gene variants linked to conditions, affected people may have Leigh syndrome or a related mitochondrial condition with muscle weakness, developmental delay, seizures, or trouble with exercise. Symptoms can vary widely, even within the same family.
A variant is not necessarily a diagnosis
Variants in genes are a normal part of human biology and are commonly seen in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MT-CO2, risk is mostly shaped by the specific mitochondrial gene change and how much of it is present in the body, so family history on the mother’s side matters most. Symptoms and severity can vary from one person to another and may become more noticeable during illness or other body stresses.
Inheritance of MT-CO2 variants
For families trying to understand the MT-CO2 inheritance pattern, variants in the MT-CO2 gene follow mitochondrial inheritance, also called maternal inheritance. This means a mother with an MT-CO2 variant can pass it to all of her children, both daughters and sons. A father does not pass mitochondrial genes, including the MT-CO2 gene, to his children. The effects can still vary from one family member to another because the proportion of altered mitochondrial DNA can differ between people.
What does my MT-CO2 result mean for my family?
There isn't yet a broadly confirmed Mendelian inheritance pattern tied to a specific condition for MT-CO2 in the way seen with many genes in the cell nucleus. Changes in MT-CO2 are in mitochondrial DNA, so family implications can look different from typical inherited gene changes. If you have a specific MT-CO2 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in context.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the MT-CO2 gene, a lab studies mitochondrial DNA from a blood, saliva, or sometimes muscle sample using genetic testing for MT-CO2 variants. The test reads the gene’s code and checks for changes, and results may also report how much of the altered mitochondrial DNA is present because this can differ between tissues.
When should I consider getting a genetic test?
Genetic testing for the MT-CO2 gene may be worth considering if you or your child has signs of a mitochondrial condition, such as unexplained muscle weakness, seizures, hearing loss, vision problems, or stroke-like episodes, especially if similar problems run through the mother’s side of the family. It can also help when a relative is known to carry an MT-CO2 variant.
A genetic result is only one part of your health story
Genetic test results can be informative, but the amount they reveal varies with the condition and the kind of variant found. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or handle a drug differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect responses to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are better informed and more individualized. If you want to learn more about this topic, additional information is available in the LearnHub.
Drugs influenced by the MT-CO2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, new symptoms after starting a medicine, or how treatments may affect your health, talk with your doctor or pharmacist.
History
MT-CO2 entered medical genetics through the broader study of mitochondrial DNA, which was mapped in detail as human mitochondrial sequences were worked out in the late 1970s and early 1980s. In 1981, researchers published the full human mitochondrial genome sequence, placing the MT-CO2 gene within a compact set of genes passed down through the maternal line. From these first observations, research expanded steadily. MT-CO2 then became part of work on mitochondrial conditions, maternal inheritance, and the use of mitochondrial DNA in tracing human ancestry. Its sequence has also been used in laboratory methods that compare mitochondrial changes across families and populations. Over time, descriptions became more precise as scientists linked specific MT-CO2 variants with particular clinical findings.